5-[(4-aminocyclohexyl)amino]-6-methyl-7-(4-phenylanilino)pyrazolo[1,5-a]pyridine-4-carbonitrile
C27H28N6 — CID 11993961
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(4-aminocyclohexyl)amino]-6-methyl-7-(4-phenylanilino)pyrazolo[1,5-a]pyridine-4-carbonitrile
5-[(4-aminocyclohexyl)amino]-6-methyl-7-(4-phenylanilino)pyrazolo[1,5-a]pyridine-4-carbonitrile (PubChem CID 11993961) has the molecular formula C27H28N6 and a molecular weight of 436.56 g/mol. Its IUPAC name is 5-[(4-aminocyclohexyl)amino]-6-methyl-7-(4-phenylanilino)pyrazolo[1,5-a]pyridine-4-carbonitrile.
Molecular Properties
| Compound Name | 5-[(4-aminocyclohexyl)amino]-6-methyl-7-(4-phenylanilino)pyrazolo[1,5-a]pyridine-4-carbonitrile |
|---|---|
| PubChem CID | 11993961 |
| Molecular Formula | C27H28N6 |
| Molecular Weight | 436.56 g/mol |
| Exact Mass | 436.24 |
| IUPAC Name | 5-[(4-aminocyclohexyl)amino]-6-methyl-7-(4-phenylanilino)pyrazolo[1,5-a]pyridine-4-carbonitrile |
| SMILES | Cc1c(NC2CCC(N)CC2)c(C#N)c2ccnn2c1Nc1ccc(-c2ccccc2)cc1 |
| InChI | InChI=1S/C27H28N6/c1-18-26(31-22-13-9-21(29)10-14-22)24(17-28)25-15-16-30-33(25)27(18)32-23-11-7-20(8-12-23)19-5-3-2-4-6-19/h2-8,11-12,15-16,21-22,31-32H,9-10,13-14,29H2,1H3 |
| InChIKey | KWCLYXSRQBVWLA-UHFFFAOYSA-N |
| XLogP | 5.61 |
| TPSA | 91.17 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.56 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11993961 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.